Status:
COMPLETED
A Study Of The Effect Of PF-04802540 On Sleep Measures
Lead Sponsor:
Taisho Pharmaceutical Co., Ltd.
Conditions:
Healthy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if PF-04802540 decreases REM sleep.
Eligibility Criteria
Inclusion
- Healthy male and/or female (nonchildbearing potential) subjects between the ages of 18 and 55 years, inclusive
- Body Mass Index (BMI) between 18 to 32 kg/m2, inclusive, and a total body weight \>45 kg (99 lbs)
- Non-users of nicotine
Exclusion
- Evidence or history of clinically significant medical illness
- A history of seizures, including childhood febrile seizures
- Any condition possibly affecting drug absorption
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00772512
Start Date
November 1 2008
End Date
February 1 2009
Last Update
March 19 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
New York, New York, United States, 10019